Misplaced Pages

Terbogrel

Article snapshot taken from[REDACTED] with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.

This is an old revision of this page, as edited by Peryeat (talk | contribs) at 00:16, 1 July 2011. The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Revision as of 00:16, 1 July 2011 by Peryeat (talk | contribs)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)
This article does not cite any sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed.
Find sources: "Terbogrel" – news · newspapers · books · scholar · JSTOR (May 2010) (Learn how and when to remove this message)
Terbogrel
Names
IUPAC name (5E)-6-{3-phenyl}-6-pyridin-3-ylhex-5-enoic acid
Identifiers
CAS Number
3D model (JSmol)
ChemSpider
KEGG
PubChem CID
InChI
  • InChI=1S/C23H27N5O2/c1-23(2,3)28-22(26-16-24)27-19-10-6-8-17(14-19)20(11-4-5-12-21(29)30)18-9-7-13-25-15-18/h6-11,13-15H,4-5,12H2,1-3H3,(H,29,30)(H2,26,27,28)/b20-11+
SMILES
  • N#CN\C(=N/C(C)(C)C)Nc2cccc(C(=C/CCCC(=O)O)\c1cccnc1)c2
Properties
Chemical formula C23H27N5O2
Molar mass 405.49
Except where otherwise noted, data are given for materials in their standard state (at 25 °C , 100 kPa). Infobox references
Chemical compound

Terbogrel blocks thromboxanes and is expected to be useful in treating the vasoconstricting and platelet aggregating action of this compound. Terbogrel is a thromboxane A2 receptor antagonist.

Se also: Ramatroban

Antithrombotics (thrombolytics, anticoagulants and antiplatelet drugs) (B01)
Antiplatelet drugs
Glycoprotein IIb/IIIa inhibitors
ADP receptor/P2Y12 inhibitors
Prostaglandin analogue (PGI2)
COX inhibitors
Thromboxane inhibitors
Phosphodiesterase inhibitors
Other
Anticoagulants
Vitamin K antagonists
(inhibit II, VII, IX, X)
Factor Xa inhibitors
(with some II inhibition)
Heparin group/
glycosaminoglycans/
(bind antithrombin)
Direct Xa inhibitors ("xabans")
Direct thrombin (IIa) inhibitors
Other
Thrombolytic drugs/
fibrinolytics
Non-medicinal
Drugs for obstructive airway diseases: asthma/COPD (R03)
Adrenergics, inhalants
Short-acting β2 agonists
Long-acting β2 agonists
Ultra-long-acting β2 agonists
Other
Glucocorticoids
Anticholinergics/
muscarinic antagonist
Mast cell stabilizers
Xanthines
Eicosanoid inhibition
Leukotriene antagonists
Arachidonate 5-lipoxygenase inhibitors
Thromboxane receptor antagonists
Non-xanthine PDE4 inhibitors
Others/unknown
Combination products
Categories:
Terbogrel Add topic